Cervical tsDCS on Stroke Patients (AMPLI-MOV)
Clinical and Neurophysiological Evaluation of the Effects of Cervical tsDCS on Stroke Patients With Distal Upper Limb Strength Deficit
The present project aims to evaluate the facilitatory modulation of motor responses of the limb upper limb by tsDCS in patients with arm/hand hyposthenia after cerebral ischemia to verify the possible therapeutic benefits that this type of stimulation can induce in terms of of strength, dexterity and effectiveness in acts of daily living.
Studie Overzicht
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Fabrizio Vecchio
- Telefoonnummer: 3478031201
- E-mail: fabrizio.vecchio@sanraffaele.it
Studie Locaties
-
-
RM
-
Roma, RM, Italië, 00166
- Werving
- IRCCS San Raffaele Roma
-
Contact:
- Fabrizio Vecchio
- Telefoonnummer: +39-06-52253767
- E-mail: fabrizio.vecchio@sanraffaele.it
-
-
Rome
-
Rome, Rome, Italië, 00163
- Nog niet aan het werven
- IRCCS San Raffaele Roma
-
Contact:
- Fabrizio v
- Telefoonnummer: 3478031201
- E-mail: fabrizio.vecchio@sanraffaele.it
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Group Stroke:
Inclusion criteria:
- age over 18 years;
- first ischemic/hemorrhagic stroke (within 30 days of onset);
- mild-to-moderate stroke (NIHSS scale score<16).
- residual function of the upper limb, assessed by the following scales: - MRC of the distal muscles of the upper limb: score between 2 and 4; - NHISS (items 5A and 5B): score between 1 and 3;
- ability to give informed consent and understand instructions.
Exclusion criteria:
- severe spasticity (Ashworth Scale score > 2);
- severe aphasia;
- severe neglect;
- history of disabling neurological disease;
- history of epilepsy;
- significant comorbidities;
- contraindications to tsDCS.
Healthy Group:
Inclusion criteria:
- age over 18 years;
- equalized in age with the patient group.
Exclusion criteria:
- history of stroke progress;
- history of severe neurological disease.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Crossover-opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Gezond
|
Transcranial direct current stimulation |
|
Experimenteel: Hartinfarct
|
Transcranial direct current stimulation |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
improvement of paretic hand performance
Tijdsspanne: through study completion, an average of 1 year
|
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Reaching |
through study completion, an average of 1 year
|
|
improvement of paretic hand performance
Tijdsspanne: through study completion, an average of 1 year
|
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Grasping |
through study completion, an average of 1 year
|
|
improvement of paretic hand performance
Tijdsspanne: through study completion, an average of 1 year
|
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Lifting test |
through study completion, an average of 1 year
|
|
improvement of paretic hand performance
Tijdsspanne: through study completion, an average of 1 year
|
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level duringthe Nine Hole Peg test |
through study completion, an average of 1 year
|
|
improvement of paretic hand performance
Tijdsspanne: through study completion, an average of 1 year
|
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during finger mobility tests |
through study completion, an average of 1 year
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RP 23/06
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .